Research Article

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis

Table 2

Association of the presence of laboratory parameters between active and inactive SLE, with and without renal involvement (mean ± SD).

Activity of SLERenal involvement of SLE
Active SLE ()Inactive SLE ()LN ()Non-LN ()

CANCA (+) number (%)0/20 (0)0/91 (0)NA0/31 (0)0/80 (0)NA
ANA (+) number (%)17/20 (85.0)55/91 (86.0)NA28/31 (90.3)44/80 (55.0)NA
Anti-Rib-P (+) number (%)2/20 (10.0)COPD11/91 (12.1)NA4/31 (12.9)9/80 (11.2)NA
Anti-SSA Ab (+) number (%)8/20 (40.0)30/91 (33.0)NA15/31 (48.4)23/80 (28.8)NA
Anti-SSB Ab (+) number (%)4/20 (20.0)11/91 (12.1)NA6/31 (19.4)9/80 (11.3)NA
pANCA (+) number (%)1/20 (5.0)1/91 (1.1)NA0/31 (0)2/80 (2.5)NA
U1RNP (+) number (%)9/20 (45.0)18/91 (19.8)NA10/31 (32.3)17/80 (21.2)NA
Anti-Smith (+) number (%)6/20 (30.0)6/91 (7.0)NA4/31 (12.9)8/80 (10.0)NA
ACA (+) number (%)15/20 (75.0)30/91 (32.4)NA20/31 (64.5)25/80 (31.3)NA
C3 (µg/mL)0.48 ± 0.180.60 ± 0.190.0000.43 ± 0.180.58 ± 0.210.0067
C4 (µg/mL)0.054 ± 0.0230.57 ± 0.0220.1460.055 ± 0.0210.088 ± 0.0260.0913
Anti-dsNDA (IU/mL)214.45 ± 103.7690.30 ± 70.170.000229.70 ± 111.05156.91 ± 102.300.045

A SLEDAI score not less than 10 was defined as active SLE. Data represented the mean ± SD; variance was analyzed by independent-samples -test using GraphPad Prism5. Ab: antibody; ACL: anticardiolipin; ANA: antinuclear antibody; LN: lupus nephritis; pANCA: perinuclear antineutrophil cytoplasmic antibody; Rib-P: ribosomal P-proteins; RNP: ribonucleoprotein; SSA: Sjogren’s syndrome A; and SSB: anti-Sjogren’s syndrome B.